FindTrial
Sign In

Key markers and intervention targets of hepatocellular carcinoma recurrence after hepatectomy

Key markers and intervention targets of hepatocellular carcinoma recurrence after hepatectomy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-BPC-17010538
Enrollment
Unknown
Registered
2017-02-01
Start date
2017-02-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

liver cancer

Interventions

Case series:Nil

Sponsors

First Affiliated Hospital of Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
80 Years to 20 Years

Inclusion criteria

Inclusion criteria: Hepatocellular carcinoma patients did not accept any treatments preoperatively, such as TACE, RFA and other treatments. And the cancer and adjacent tissues are accessible.

Exclusion criteria

Exclusion criteria: Hepatocellular carcinoma patients accepted treatments preoperatively, such as TACE, RFA and other treatments.

Design outcomes

Primary

MeasureTime frame
HCC recurrence;—

Countries

China

Contacts

Public ContactLiu Zhikun

First Affiliated Hospital of Zhejiang University

liuzk@zju.edu.cn+86 13758187589

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026